Trajenta 5 mg tablets contain linagliptin, a DPP-4 inhibitor used to improve glycemic control in adults with type 2 diabetes mellitus./Description: Trajenta (linagliptin) is an oral antidiabetic medication that enhances the body's natural ability to regulate blood sugar levels. As a dipeptidyl peptidase-4 (DPP-4) inhibitor, it increases incretin levels, which in turn stimulate insulin release and decrease glucagon levels in a glucose-dependent manner. This helps to lower blood glucose levels in adults with type 2 diabetes. Trajenta is typically used in conjunction with diet and exercise and may be prescribed alone or in combination with other antidiabetic medications.. Please Note that product description, color, ingredients, package and other information maybe different from the original pack kindly check the product for more accurate details.
